Company

Pixium Vision SA

Headquarters: Paris, France

Employees: 28

CEO: Mr. Lloyd Diamond

Euronext: ALPIX

Market Cap

€2.1 Million

EUR as of Jan. 1, 2024

US$2.3 Million

Market Cap History

Pixium Vision SA market capitalization over time

Evolution of Pixium Vision SA market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Pixium Vision SA

Detailed Description

Pixium Vision SA, a bioelectronics and brain machine interface technology company, specialized in neuromodulation application. It develops PRIMA System, a bionic vision system for patients with severe vision loss due to retinal degeneration caused by the dry atrophic form of Age-related Macular Degeneration (AMD); and to treat bilndness, which replace the normal physiological function of the eye's photoreceptor cells by electrically stimulating the nerve cells of the inner retina, which then transmit the visual information to the brain via the optic nerve. The company has collaboration agreements with Stanford University in California, Institut de la Vision, Moorfields Eye Hospital, Institute of Ocular Microsurgery, University Hospital, and UPMC. Pixium Vision SA was founded in 2011 and is based in Paris, France.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Pixium Vision SA has the following listings and related stock indices.


Stock: Euronext: ALPIX wb_incandescent

Stock: FSX: PXH wb_incandescent

Details

Headquarters:

74 rue du Faubourg Saint-Antoine

Paris, 75012

France

Phone: 33 1 76 21 47 68

Fax: 33 1 43 42 05 26